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ABSTRACT 
 
The current meta-analysis aimed to quantify the effectiveness of hypnosis for 
reducing pain and identify factors that influence efficacy. Six major databases were 
systematically searched for trials comparing hypnotic inductions with no-
intervention control conditions on pain ratings, threshold and tolerance using 
experimentally-evoked pain models in healthy participants. Eighty-five eligible 
studies (primarily crossover trials) were identified, consisting of 3632 participants 
(hypnosis n=2892, control n=2646). Random effects meta-analysis found analgesic 
effects of hypnosis for all pain outcomes (g=0.54-0.76, p’s<.001). Efficacy was 
strongly influenced by hypnotic suggestibility and use of direct analgesic suggestion. 
Specifically, optimal pain relief was obtained for hypnosis with direct analgesic 
suggestion administered to high and medium suggestibles, who respectively 
demonstrated 42% (p<.001) and 29% (p<.001) clinically meaningful reductions in 
pain. Minimal benefits were found for low suggestibles. These findings suggest that 
hypnotic intervention can deliver meaningful pain relief for most people and 
therefore may be an effective and safe alternative to pharmaceutical intervention. 
High quality clinical data is, however, needed to establish generalisability in chronic 
pain populations. 
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1 INTRODUCTION 
Pain affects up to 1.5 billion adults worldwide (Yaqub, 2015) and has a substantial 
negative impact on quality of life. In addition to becoming one of the leading causes 
of years lived with disability (GBD Causes of Death Collaborators, 2017), pain also 
incurs a massive economic burden. Pain-related health care and lost productivity 
incur annual costs of up to $635 billion in the US alone (Gaskin and Richard, 2012), 
greater than that of heart disease, cancer or diabetes. Increasing concern over the 
side effects, addictive properties and costs of opioid medication has led to an urgent 
need to identify non-pharmacological interventions for pain that are effective, safe, 
and inexpensive. 
 
One popular psychological intervention for pain management is hypnosis, which 
typically involves relaxation, focused attention and targeted verbal suggestion to 
alter perceptual experience and behaviour (Jensen and Patterson, 2014). Hypnosis is 
easily administered, has few or no side effects, and is inexpensive if delivered in a 
pre-recorded format (e.g., audio recording) that does not require the presence of a 
practitioner (Jensen et al., 2015).  Recent research has indicated that hypnotic 
suggestion produces altered activity in key regions of the brain involved in pain 
regulation, including the anterior cingulate, prefrontal and insular cortices (Del 
Casale et al., 2015), and this could provide a basis for possible analgesic effects. 
Exaggerated claims of hypnotic analgesia have, however, created scepticism over its 
efficacy (Larkin, 1999), and a rigorous evaluation of controlled trials is needed to 
properly evaluate and quantify its effectiveness for reducing pain.  
 
A recent meta-analysis of 14 trials of people with chronic pain (Adachi et al., 2014) 
concluded that hypnosis was effective for managing pain. However, this conclusion 
was based primarily on a subset of 4 studies comparing hypnosis with standard care 
(d=.60, CI95[0.03, 1.17]) that was largely unreplicated in other subset comparisons. 
Individual study findings were inconsistent, probably resulting from variation in pain 
conditions, control comparisons (e.g. treatment-as-usual, no intervention) and 
hypnotic suggestibility of study samples, and thus this meta-analysis provides an 
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unclear overall picture of the analgesic benefits of hypnosis.  Other reviews have 
indicated beneficial effects of hypnosis on labour pain (Madden et al., 2016), and 
fibromyalgia (Bernardy et al., 2011), but have all concluded that supporting clinical 
evidence is of low methodological quality.  
 
The effect of hypnosis on pain has also been examined using experimental 
paradigms to provide a level of methodological control difficult to achieve in clinical 
settings. A meta-analysis of 18 studies that included 12 experimental and 6 clinical 
trials (Montgomery et al., 2000) found significant moderate analgesic effects of 
hypnosis (d=.67). While this represents an important finding, several important 
limitations driven primarily by a lack of available data should be noted. First, 
determining the level of meaningful analgesia from hypnosis is difficult given the 
absence of a metric on which meaningful clinical change can be mapped (e.g. 0-10 
numerical ratings). Second, estimates of hypnotic analgesia were complicated by 
considerable heterogeneity in control comparators. Third, factors such as hypnotic 
suggestibility and the use of direct analgesic suggestion that may be critical to 
treatment success (Patterson and Jensen, 2003) could not be adequately assessed. A 
large number of experimental studies have been published since this meta-analysis 
from almost 20 years ago, thereby providing a new opportunity for more reliable 
estimates of the effectiveness of hypnosis for pain reduction and to assess potential 
moderating factors.  
 
To fill the gap in current knowledge regarding the efficacy of hypnosis for pain, we 
conducted a meta-analysis comparing hypnotic interventions with no-treatment 
control in studies using experimental pain models in healthy participants. Specific 
aims were to obtain precise estimates of: (1) the magnitude of hypnotic analgesia on 
standardized and unstandardized scales (e.g. 0-10 ratings); and (2) the degree to 
which intervention effectiveness is dependent upon both hypnotic suggestibility and 
the inclusion of direct suggestions of pain relief. 
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2 METHOD 
This systematic review was conducted in accordance with the PRISMA-P 2015 
statement for systematic review and meta-analysis protocols (Moher et al., 2015). 
An a priori but unpublished protocol was followed (available from the authors upon 
request). 
2.1 Eligibility Criteria 
Inclusion criteria were: (1) a hypnotic induction; (2) a non-hypnosis control condition 
with no active intervention; (3) an experimental pain stimulus administered to 
healthy participants; and (4) a quantitative assessment of pain. Although there is no 
established consensus for a definition of a hypnotic induction (Terhune and Cardeña, 
2016), we used the conceptualisation by Jensen and Patterson (2014) of suggestions 
offered to another person to alter perceptual experience and voluntary action that 
typically involves relaxation, focused attention and/or imagery. Exclusion criteria 
were: (1) hypnosis induced by a pharmacological agent (e.g. ketamine); or (2) co-
administration of hypnosis with other intervention(s). 
2.2 Search Strategy 
PubMed, EMBASE, PsycINFO, CINAHL, CENTRAL and Web of Science databases were 
searched independently by two reviewers (RR, JS) for potentially eligible studies 
indexed from database inception until 21st May, 2018.  
 
The search string consisted of three elements related to hypnosis AND pain AND 
experimental noxious stimuli (see Appendix S1). Specific free text words chosen for 
experimental pain methods were derived from Gracely (2005) and our previous 
meta-analyses (Thompson et al., 2017a; Thompson et al., 2017b). Searches were 
applied to all database fields where possible, or title/abstract/keywords where this 
restriction was imposed by the database. Results were limited a posteriori to ‘human 
studies’ and searches were augmented through manual searches of reference lists of 
included articles and reviews. 
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2.3 Study selection 
Titles and abstracts of articles returned by initial searches were independently 
screened by two reviewers (RR, JS) who rejected articles not meeting eligibility 
criteria. The full-text of remaining articles was independently examined by the same 
reviewers to reach a final list of articles. Disagreements at either screening stage 
were resolved through discussion with a third reviewer (TT). When an eligible article 
provided insufficient data for inclusion, corresponding authors were contacted up to 
3 times over an 8-week period to request additional data. Of 20 author groups 
contacted, 6 (30%) provided data sufficient to permit study inclusion (see 
acknowledgements section). 
2.4 Pain outcomes  
Outcome variables were: (1) self-reported pain ratings (e.g. 0-10 rating scale), (2) 
pain tolerance and (3) pain threshold. Pain threshold is the point at which pain is first 
detected and tolerance is the point at which pain can no longer be endured, with 
both measures typically quantified as stimulus intensity (e.g. temperature) or 
exposure time.  
 
Pain ratings were included to provide a clinically meaningful measure of pain, with 
threshold and tolerance included as they represent behavioural responses to 
minimal and maximal pain respectively. 
2.5 Study quality 
Two raters (RR, JS) independently rated each study for methodological quality on a 
15-item validity scale assessing methodological rigour, selection and reporting bias 
(Table S1). Items were based on Cochrane criteria and PRISMA recommendations, 
and were adapted from Thompson et al. (2017a) for the current review. 
2.6 Data Extraction 
Extraction and coding of study data were performed by three authors (CO, RR, JS) on 
a standardized template (Thompson et al., 2017a), with all data entry checked by 
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another reviewer (TT). The following data were extracted: (1) pain outcomes; (2) 
sample characteristics: age, gender, hypnotic suggestibility; (3) study characteristics: 
location, design, pain induction method; (4) hypnotic induction: method (e.g. 
Stanford procedure), format (e.g. verbal, virtual reality), direct suggestions of 
analgesia (present, absent), number/duration of sessions, control condition (nothing, 
placebo). For pain outcomes, when a study did not report Ms and SDs, effect sizes 
were calculated from any other statistics that allowed their computation based on 
standardised formulae (Cooper et al., 2009). 
 
When a study provided data for multiple effect sizes (e.g. across different time 
points), all such data were extracted. In addition, the following extraction decisions 
were made: (1) for a few studies that did not report Ms/SDs but did report 
significance thresholds (e.g. p<.01), we conservatively rounded these to absolute p-
values (e.g. p=.01) to compute effect size; (2) for a few studies that reported use of 
hyperalgesic (pain increasing) and analgesic suggestions across different hypnotic 
conditions, only analgesic data were extracted; (3) data from a few studies (k=3) that 
used control conditions involving reading, relaxation or a simple cognitive task were 
included, as although not entirely inactive, these were considered unlikely to have 
substantial analgesic effects; (4) for a few studies (k=5) that collected pain ratings 
using a tolerance model (where stimulus intensity/exposure time can potentially 
vary across groups), pain outcome data were included. This was a conservative 
strategy, as all studies reported longer exposure times for hypnosis, so pain ratings 
in this condition would not be expected to be reduced due to the use of a tolerance 
model. For (1), (3) and (4), sensitivity analyses were conducted to examine their 
impact on effect size. 
2.7 Hypnotic suggestibility 
Hypnotic suggestibility is the degree of responsiveness to suggestions made within a 
hypnotic induction. Scoring is typically based on the aggregation of behavioural 
responses to a series of individual suggestions (e.g. whether suggestions of 
heaviness or tiredness in the arm produce lowering of the hand by 6 inches or more) 
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(Weitzenhoffer and Hilgard, 1962). Study samples were classified as low, medium or 
high in hypnotic suggestibility if scores on standardised measures fell within the 
following ranges: (a) Harvard Group Scale of Hypnotic Suggestibility:Form A 
(HGSHS:A) and Stanford Hypnotic Suggestibility Scale (SHSS) forms A and C: low (0-
4), medium (5-7), high (8-12) (Shor and Orne, 1963; Weitzenhoffer and Hilgard, 
1962); (b) Carleton University Responsiveness to Suggestion Scale: Objective 
dimension (CURSS:O): low (0-2), medium (3-4), high (5-7) (Spanos et al., 1983b); and 
(c) Stanford Hypnotic Arm Levitation Induction and Test (SHALIT): low (0-3), medium 
(4-7), high (8-12) (Hilgard et al., 1979). 
 
Classifications were made using two different methods. First, a study sample was 
classified as low, medium or high suggestibility if the reported study range fell within 
the above normative boundaries (k=40). Second, as sometimes only mean scores 
were reported or ranges did not precisely match normative ranges, we used an 
alternative, less stringent classification to maximise study inclusion (k=67) for 
moderation analysis. Specifically, we made additional classifications when (a) the 
mean suggestibility score fell within normative boundaries (and range was not 
reported), or (b) reported study ranges closely approximated normative guidelines 
(e.g. when 0-5, rather than 0-4, was reported for the Stanford scale). We employed 
the less stringent classification in moderation analysis, but performed sensitivity 
analysis to evaluate the impact of this decision.  
2.8 Effect size 
The standardized mean difference (SMD) for hypnosis vs. control was computed with 
Hedges' g formula (Cooper et al., 2009), where 0.20, 0.50 and 0.80 can be broadly 
translated as small, medium and large effects (Cohen, 1988). SMDs for all studies 
were computed using original (unadjusted) standard deviations, but effect size 
variance was computed dependent upon study design (Morris and DeShon, 2002). 
Effect sizes were coded so that positive values indicated beneficial effects of 
hypnosis (i.e. a decrease in pain ratings or an increase in threshold/tolerance). 
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2.9 Meta-analysis 
A random-effects model was used as heterogeneity in effect size due to variation in 
study methodology is likely. As studies typically report multiple effect size data (e.g. 
from the same subjects across multiple time points), we used a robust variance 
estimation (RVE) method (Hedges et al., 2010) to account for within-study 
dependency of effect sizes. In RVE, individual weights are based on the true common 
correlation of within-study effect sizes. Although this value is usually unknown, 
simulation studies have shown that different correlations tend to have little impact 
on results (Tanner-Smith and Tipton, 2014; Hedges et al., 2010). We used r=0.65 as 
our estimated correlation as this approximated that typically reported by studies 
employing repeated testing, but conducted sensitivity analysis using lower (r=.40) 
and higher (r=.90) correlations to examine the effect on parameter estimates. RVE 
meta-analysis estimates are most reliable when 10 or more studies are available 
(Tanner-Smith and Tipton, 2014). A few studies collected pain ratings on scales other 
than 0-10 (e.g. 0-20), and these were transformed to a 0-10 scale. 
2.10 Meta-regression 
RVE meta-regression analyses were performed to identify potential sources of 
heterogeneity size if moderate or greater inconsistency was found, as indicated by  
I2>50% (Higgins et al., 2003) and 40 or more studies were available (Tanner-Smith 
and Tipton, 2014).  
 
Primary moderators were: (1) hypnotic suggestibility (low/medium/high), and (2) 
direct analgesic suggestion (present/absent), with the hypothesis that hypnosis 
would produce greater analgesia when participants were higher in hypnotic 
suggestibility and direct suggestions of pain relief were present. 
 
Secondary moderators were examined to provide preliminary data on any 
moderating influence of hypnosis method, format (audio recording/live), comparison 
group (control/placebo), study age, gender composition and pain induction method. 
Where the endorsement of important study validity criteria varied across studies, 
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the influence of these criteria as potential moderators of effect size was also 
assessed.  
2.11 Publication bias 
To assess potential publication bias, funnel plots of average study effect sizes against 
standard errors were examined for asymmetry resulting from a relative lack of small 
studies with small effect sizes (i.e. those most likely to be non-significant and remain 
unpublished). Asymmetry was also tested statistically with Egger’s bias test (Egger et 
al., 1997) with p<.05 indicating asymmetry. If evidence of asymmetry was present, a 
revised effect size was computed using the trim and fill method (Duval and Tweedie, 
2000).  
 
All analyses were performed using the robumeta (Fisher and Tipton, 2014) and 
metafor (Viechtbauer, 2010) packages in R (R Core Team, 2017). 
 
3 RESULTS 
3.1 Study inclusion  
An initial pool of 4,801 unique studies were identified through database searches, 
with 14 additional records acquired through manual searching of reference lists. 
Screening of titles/abstracts identified 229 potentially eligible articles, with full-text 
review resulting in a final list of 85 eligible studies (see Figure 1). Key characteristics 
of these studies are presented in Table 1. 
3.2 Participant characteristics  
The 85 studies provided data for 3,632 participants (hypnosis n=2,892, control n= 
2,646, with crossover trials primarily used). Mean study age (reported by k=28 of 85 
studies) was 24.6 years (SD=4.5) for hypnosis and 25.4 years (SD =4.4) for controls. 
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Mean gender composition (k=62) was 63.5% female (SD=22.4) for hypnosis and 
63.1% female (SD =23.8) for controls.  
3.3 Study characteristics 
Study designs used were crossover (k=61), pre-post control (k=22) and parallel 
groups (k=2). Study locations were USA (k=32), Italy (k=16), Canada (k=15), Germany 
(k=4), UK (k=3), France (k=3), Belgium (k=3), Denmark (k=2), Israel (k=2), Netherlands 
(k=1), Australia (k=1), New Zealand (k=1), Romania (k=1) and Switzerland (k=1). 
3.4 Pain assessment and induction 
Different pain assessment (ks: intensity ratings=66, affective ratings=24, 
tolerance=18, threshold=16) and pain induction (ks: cold=23, electric=22, 
pressure=19, heat=16, ischemic=5, laser=2) methods were used, with multiple 
assessment and induction methods within a single study sometimes employed. 
Noxious stimuli were most commonly applied to the hand (k=62) or forearm/upper 
arm (k=12). 
3.5 Hypnotic induction and suggestibility  
Details of hypnotic induction procedures are provided in Table 1, which we broadly 
categorised as standard/typical hypnotic procedures (k=55) and standardized (e.g. 
HGSHS/SHSS) inductions (k=30) (both procedures typically include combinations of 
eye fixation, progressive relaxation and suggestions of drowsiness). Direct analgesic 
suggestions (e.g. ‘you cannot feel pain because the glove you are wearing prevents 
you from feeling it’) were present (k=72) and/or absent (k=37) and hypnosis was 
delivered in several formats (ks: live=68, recorded audio=19, virtual media=3). 
Comparison conditions consisted of an inactive control (k=83) and/or a placebo 
condition (k=8) such as a sham analgesic spray. 
 
Hypnotic suggestibility was assessed in 78 studies primarily using the SHSS (k=35; 
form C=28, form A=7), HGSHS:A (k=23), CURSS:O (k=19), SHALIT (k=2) and/or WSGC 
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(k=2) tests. Most studies used a single session of hypnosis (k=74), with a small subset 
using two (k=10) or three sessions (k=1) with sessions usually lasting 15-30 mins. 
3.6 Study validity criteria  
Study ratings for each validity criteria are shown in Appendix S2. Although most 
study criteria were well met, several criteria were not. Perhaps most importantly, 
only 42% of studies explicitly reported random allocation/counterbalancing. More 
specifically, 18/24 (75%) parallel/pre-post control designs reported random group 
allocation, and only 18/61 (30%) crossover studies counterbalanced/randomised 
presentation order, with control procedures typically occurring first. As this could 
potentially result in bias from habituation or sensitisation to repeated pain 
stimulation, the impact of randomisation vs. non-randomisation on effect size was 
examined in moderation analysis. Only a few studies screened participants for pre-
existing pain (18%) or gave details on use of pain medication (25%), although these 
would seem less likely to present serious threats to overall conclusions given the 
primary use of crossover designs. 
3.7 Rater agreement 
For study selection, good rater agreement was shown at the full-text review stage 
(95% agreement, kappa=.80), with initial discrepancies primarily due to uncertainty 
over control group eligibility. For ratings of validity criteria, acceptable agreement 
was demonstrated for the majority of the individual items (agreement=77-99%; 
kappa=0.45-0.92) with agreement lowest for adequacy of control group description 
(77%) and recruitment procedures (83%). In all cases of disagreement, 100% 
consensus was reached after discussion with a third reviewer (TT).  
3.8 Outliers 
Studentized residuals>3.3 from initial meta-analysis (Viechtbauer and Cheung, 2010) 
suggested one potential outlier for tolerance (Casiglia et al., 2007), one for pain 
affect (Price and Barber, 1987) and two for pain intensity (Faymonville et al., 2003; 
Crawford et al., 1993). Although no obvious reason for these outlying values could 
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be identified from further scrutiny of these papers, these cases were conservatively 
removed to prevent potential distortion of results (as these were all high positive 
values, removal resulted in marginally reduced, rather than inflated, effect sizes). 
3.9 Meta-analysis 
 Pain ratings: Intensity 
Meta-analysis of 64 studies (205 effect sizes) of pain intensity across 3,039 
participants (hypnosis n=2,366, control n=2,168), found hypnosis to result in lower 
overall pain intensity, SMD=0.74, CI95[0.63, 0.84], p<.001 (Figure 2), classifiable as a 
large effect (Cohen, 1988). Positive effect sizes were found in all but one study, but 
with high inconsistency in magnitude (I2=75%).  
 
Analysis of 52 studies which provided raw, unstandardized 0-10 ratings were 
consistent with these results (Mean Difference=1.49, CI95[1.21, 1.78], p<.001). A 
decrease from 5.5 to 4.0 points was observed with hypnosis, a reduction of around 
27% or 1.5 points.  
 Pain ratings: Affect 
Meta-analysis of 23 studies (103 effect sizes) of 751 participants (hypnosis n=665, 
control n=587) revealed similarly lower affective pain ratings for hypnosis, 
SMD=0.76, CI95[0.53, 0.99], p<.001. High inconsistency in effect size was observed 
(I2=78%), although positive effect sizes were observed for all 23 studies. Analysis of 
unstandardized 0-10 pain affect ratings from 18 studies indicated a mean reduction 
of 1.53 points, CI95[1.14, 1.93], p<.001, for hypnosis. 
 Pain tolerance 
Meta-analysis of 17 studies (33 effect sizes) of 696 participants (hypnosis n=536, 
control n=470) indicated higher tolerance (i.e. reduced pain) for hypnosis, 
SMD=0.54, CI95[0.38, 0.70], p<.001. Positive effects were indicated in all studies, but 
with moderate inconsistency in effect size (I2=56%).  
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 Pain threshold 
Meta-analysis of 16 studies (64 effect sizes) of 415 participants (hypnosis n=382, 
control n=380) found higher pain threshold (i.e. reduced pain) for hypnosis, 
SMD=0.66, CI95[0.38, 0.70], p<.001. Positive effects were found for all studies, but 
with high inconsistency (I2=78%).  
3.10 Publication bias 
Funnel plots and Egger’s test suggested asymmetry in pain intensity (z=2.39, p=.017), 
tolerance (z=2.30, p=.022) and threshold (z=2.06, p=.039), that was consistent with 
possible publication bias. Trim and fill estimates produced slight reductions in effect 
sizes for intensity (ΔSMD=-.06; Figure 3), tolerance (ΔSMD=- .06) and threshold 
(ΔSMD=-.04). 
3.11 Meta-regression 
Meta-regression was performed for pain intensity only as study numbers (k=64) 
were considerably higher than other pain outcomes (ks=16-23) and thus provide 
more reliable parameter estimates.  
 Primary moderators 
Analgesic suggestion (yes, no) and hypnotic suggestibility (low, medium, high) were 
entered simultaneously as dummy-coded moderators, with no analgesic suggestion 
and low suggestibility coded as reference levels. Both variables were well 
represented by studies across their different levels (hypnotic suggestibility: low=31, 
medium=15, and high=43 studies; analgesic suggestion: yes=48, no=24 studies). 
 
Meta-regression parameter estimates are shown in Table 2 for unstandardized (0-
10) ratings and indicate greater pain relief for increasing suggestibility (+0.64 for 
medium, +1.34 points for high) and inclusion of a direct analgesic suggestion (+0.94 
points). Solving the regression equation at different predictor values revealed that 
relative to control pain intensity ratings of 5.5, hypnosis with direct analgesic 
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suggestion decreased pain by: 2.30 points (CI95[1.82, 2.80], p<.001) in high 
suggestibles (42% reduction), 1.60 points (CI95[1.23, 1.99], p<.001) in medium 
suggestibles (29% reduction), and 0.97 points (CI95[0.61, 1.32], p<.001) for low 
suggestibles (17% reduction).  
 
Hypnosis with no direct analgesic suggestion decreased pain ratings by: 1.36 points 
(CI95 [0.48, 2.28], p=.004) in high suggestibles (25% reduction), 0.67 points (CI95[0.10, 
1.23], p=.025) in medium suggestibles (12% reduction), and 0.03 points (CI95[-0.65, 
0.59], p=.931) in low suggestibles (0.5% reduction), with the latter result not 
significant. 
 Secondary moderators 
Separate meta-regression was performed for the following moderators after 
removing levels of any variable with low (<5) study numbers: delivery format (audio 
recording, live), hypnotic induction method (standard procedure, standardized 
induction), comparison (control, placebo), pain induction (heat, electric, pressure, 
cold), age and study gender composition. We also examined whether randomisation 
vs. non-randomisation influenced effect size (Section 3.6). Results indicated hypnotic 
analgesia was marginally lower (ΔSMD=-.01) for studies reporting randomization 
(primarily of presentation order) relative to those that did not, but this was not 
significant (p=.90). No secondary moderators were significant (ps=.22-.85). 
3.12 Sensitivity analysis 
We re-ran analyses using alternative correlations of effect sizes (section 2.9), using 
more stringent hypnotic suggestibility classifications (section 2.7), and with 
extraction decisions specified in Section 2.6, but found no substantive changes in 
parameter estimates. 
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4 DISCUSSION 
The effectiveness of hypnosis for reducing pain was supported by meta-analysis of 
85 controlled experimental trials totalling 3,632 participants. Key findings were: (1) 
hypnosis produced moderate to large overall analgesia for all pain outcomes; (2) 
hypnotic suggestibility and the inclusion of a direct analgesic suggestion are 
important determinants of intervention effectiveness; and (3) possible publication 
bias was identified, but had minimal impact on effect sizes.  
4.1 Magnitude of pain relief 
Hypnosis with analgesic suggestion produced a 42% reduction in pain intensity for 
those with high hypnotic suggestibility and a 29% reduction for those with medium 
hypnotic suggestibility. This is broadly supportive of a meaningful level of analgesia 
based on established guidelines for clinically important change, where a ≥30% 
reduction in pain typically represents ‘much improved’ (although ≥50% reductions 
are needed for ‘very much improved’)(Dworkin et al., 2008).  
 
Importantly, pain relief approaching or exceeding 30% was dependent upon (1) the 
inclusion of direct suggestion of pain relief, and (2) a target population of individuals 
high or medium in hypnotic suggestibility. Insofar as the majority of the general 
population (85-90%) fall into the medium to high hypnotic suggestibility range 
(McConkey, 2012), these findings suggest that most individuals are able to 
experience meaningful analgesia from hypnosis provided direct analgesic 
suggestions are included. Hypnotic suggestibility has also been shown to influence 
efficacy of hypnosis in clinical care settings, although a meta-analysis of 10 studies by 
Montgomery et al. (2011) found relatively small moderating effects and questioned 
the usefulness of pre-assessing hypnotic suggestibility. However, Montgomery et al. 
(2011) examined a broad range of medical, dental and mental health conditions that 
included only 3 available pain studies, and thus further data is needed before 
conclusions on generalisability to clinical pain contexts can be made. 
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4.2 Previous findings 
Analgesic effects of hypnosis in experimental pain trials are consistent with a 
previous meta-analysis published almost 20 years ago (Montgomery et al., 2000). 
Due to a vastly increased number of experimental pain trials in the current (85 
studies) compared to the original meta-analysis (12 studies), current findings were 
also able to provide precise estimates of analgesia on a more meaningful (0-10) 
metric. We were also able to identify hypnotic suggestibility and use of analgesic 
suggestion as important determinants of treatment efficacy, as has long been 
suspected (Patterson and Jensen, 2003). Beneficial effects of hypnosis on pain have 
also been supported in reviews of labour pain (Madden et al., 2016), fibromyalgia 
(Bernardy et al., 2011) and other pain conditions (Adachi et al., 2014), although 
these reviews acknowledge the low quality of methodological evidence. 
4.3 Implications 
The present analysis has several important implications. Hypnosis may be an 
effective intervention for pain that could be offered as a safe alternative to 
medication, especially where concerns exist for an individual over the effectiveness, 
addictive potential or side effects of drug treatment. If hypnosis could be 
administered as effectively at home (e.g., in the form of pre-recorded audio) as 
during live sessions with a practitioner, then this could also provide an inexpensive 
treatment option for pain. This would be of considerable potential benefit given that 
the costs of prescription opioid addiction alone are estimated at over $78 billion 
annually in the US (Seth et al., 2018). However, while moderation analysis found no 
differences in analgesia between recorded audio and live hypnosis, suggesting the 
former may be similarly effective, we examined delivery format only as a secondary 
moderator. Furthermore, we did not perform an economic analysis, and so no claims 
of improved cost-effectiveness relative to opioids can therefore be made from the 
current study. 
 
Hypnotic interventions should also include direct suggestions of analgesia and 
delivered to a high/medium hypnotic suggestibility target population to be most 
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effective. As high/medium hypnotic suggestibility represents the majority of the 
population, this suggests treatment may be widely effective. Although the extent to 
which hypnotic suggestibility moderates treatment efficacy for clinical outcomes has 
yet to be firmly established (Montgomery et al., 2011), brief suggestibility screening 
(e.g., Morgan and Hilgard, 1978) may help identify therapeutic targets likely to 
demonstrate optimal benefits from hypnosis. In addition, some evidence indicates 
hypnotic suggestibility can be increased through training and practice (Patterson and 
Jensen, 2003), non-invasive brain stimulation (Dienes and Hutton, 2013; Coltheart et 
al., 2018), and pharmacological agents (Whalley and Brooks, 2009), and general 
engagement improved with the use of virtual reality formats (Thompson et al., 
2011), which may help increase efficacy in those with low suggestibility.  
4.4 Mechanisms 
Although the precise analgesic mechanisms underpinning hypnosis have yet to be 
established, several explanations have been considered. Imaging studies reliably 
show hypnoanalgesic suggestion to alter activity in the anterior cingulate cortex, 
insular and prefrontal areas (Del Casale et al., 2015), possibly reflecting the role of 
these brain regions in mental relaxation, absorption and stimuli-awareness. As these 
areas also form a critical part of the pain neuromatrix, which plays an important part 
in pain modulation (Jensen and Patterson, 2014), this could provide a neural basis 
for hypnotic analgesia. The anterior cingulate and frontal regions may also differ 
across low and high suggestibles in both their structural properties and their 
activation in response to hypnotic induction (Jensen et al., 2017), which could 
account for the differential effectiveness of hypnosis across these groups. 
 
Psychological models suggest that hypnotic induction produces an attentional shift 
away from external perceptual information which decreases monitoring of sensory 
cues and thus reduces pain (Jensen and Patterson, 2014). The fact that analgesia 
appears to be far more pronounced in those with high suggestibility is perhaps 
unsurprising, given that a greater responsivity to or willingness to engage with the 
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psychological components of an intervention would seem likely to enhance any 
therapeutic effects.  
4.5 Limitations 
The current findings have several important limitations. First, although evoked-pain 
models allow precise experimental control, chronic pain is often more sustained, 
diffuse and distressing, and this may threaten generalisability of the current findings 
to clinical pain (Arendt-Nielsen and Hoeck, 2011). Nevertheless, evidence from the 
current findings of meaningful pain reduction suggest a promising foundation for 
hypnosis as a clinical pain management technique. Second, relatively brief, one-off 
pain inductions were typically used, and the efficacy of hypnosis may decrease (or 
increase) over longer time periods. Third, reduced self-reported pain ratings might 
be partly attributable to undetected biases such as demand characteristics and 
response expectancies (Lynn et al., 2008). This concern may be partly mitigated by 
the analgesic effects of hypnosis for behavioural (threshold/tolerance) measures 
found here, and on ‘objective’ biomarkers such as altered brain activity in the pain 
matrix (Del Casale et al., 2015) and reduced medication requests in clinical settings 
(Lang et al., 2000; Montgomery et al., 2007) in previous studies. Fourth, the low 
mean study age (M=24.5, SD=4.4) questions applicability of findings to older 
populations where non-pharmacological interventions have the potential to be most 
useful due to increased sensitivity to the adverse effects of medication (Thompson 
et al., 2017c). Finally, we are unable to comment on the relative efficacy of hypnosis 
compared to analgesic medication, and there appear to be few, if any, primary 
studies that have directly compared the two.  
4.6 Future studies 
Additional well-controlled research establishing whether the current findings 
generalise to clinical pain is critical for establishing the viability of hypnosis as an 
effective pain intervention. Although the role of hypnotic intervention in clinical pain 
settings is well researched, limited high quality data with numerous design biases 
prohibits reliable conclusions (Bernardy et al., 2011; Birnie et al., 2014; Landolt and 
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Milling, 2011) and further well-controlled clinical studies are needed. In addition, the 
use of experimental models that produce hyperalgesic states (e.g. through capsaicin 
inflammation) and that mimic key pathological features of central sensitization in 
chronic pain but with strict experimental control (Chizh, 2007) are also likely to 
provide valuable insights.  
4.7 Conclusions 
This is the largest meta-analysis to date investigating the effectiveness of hypnosis as 
a technique for pain reduction. Evidence from 85 controlled studies provides 
convincing evidence that hypnosis produces substantive analgesia, with optimal pain 
relief delivered when direct analgesic suggestions are used in a target population of 
individuals high in suggestibility. Overall, the findings that hypnotic induction 
resulted in a reliable decrease in experimentally-induced pain suggest that hypnosis 
may represent a potentially effective and safe alternative or adjunct to 
pharmacological intervention for acute pain. Well-controlled studies of non-
laboratory pain are, however, essential to establish the efficacy of hypnosis for the 
treatment and management of clinical pain. 
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Table 1. Summary characteristics of included studies.
Study Study 
Design
N 
Hyp
N 
Control
Hypnotic Induction Procedure Delivery Analgesic 
Suggestion 
Control Procedure Pain 
Induction
Pain 
Measure
Derbyshire et al, 2017 RM 15 15 Standard hypnotic instructions with relaxation 
and imagery including suggestions to alter pain 
(e.g. to imagine pain on a dial with instructions 
to turn the dial down)
Live Yes, No Nothing Heat Intensity
Bhatt et al, 2017 RM 14 14 Standard hypnotic procedure lasting 30 mins 
with relaxation and positive imagery with 
analgesic suggestion (e.g. ‘imagine the arm 
being completely filled with sensation of relief’)
Live Yes Nothing Heat Intensity 
Threshold
Tolerance
Fidanza et al, 2017 RM 51 51 Standard hypnotic instructions with and without 
glove analgesia
NS Yes, No Nothing Electric Intensity
Casiglia et al, 2017 RM 8 8 Standard hypnotic induction with disassociation 
(e.g. ‘the hand no longer belongs to the body’)
Live No Nothing Cold Intensity 
Tolerance
Braboszcz et al, 2017 RM 11 11 Standard hypnotic induction with relaxation and 
pleasant imagery plus analgesic suggestion (e.g. 
‘your arm cannot feel anything’)
Live through 
headphones
Yes Nothing Heat Threshold
Wolf et al, 2016 RM 37 37 Standard hypnotic induction Live No Nothing Pressure Intensity 
Threshold
De Pascalis et al, 2016 RM 51 51 Stanford Hypnotic Clinical Scale Live No Nothing, but told 
may receive 
analgesic or sham 
cream 
Cold Affect
De Pascalis et al, 2015 RM 20 20 Stanford Hypnotic Clinical Scale Live Yes, No Relaxation Electric Intensity 
Affect
Kramer et al, 2014 RM 23 23 Fixation method + recall feelings of wellbeing Live No Nothing Cold + Heat 
+ Pressure
Threshold 
Swain et al, 2014 RM 120 120 *Standard hypnotic induction Live / DVD No Nothing Cold Intensity 
Tolerance 
Enea et al, 2014 PPC 60 30 Stanford SHSS:C Live Yes Nothing Pressure Intensity 
Affect
Valentini et al, 2013 RM 24 24 Stanford SHSS:A Live Yes Nothing Heat Intensity 
Affect
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Santarcangelo et al, 
2013 
RM 40 40 Standard hypnotic induction with relaxation and 
pleasant imagery, plus glove analgesic 
suggestion (e.g. ‘you cannot feel pain because 
the glove you are wearing prevents you from 
feeling it’)
Live Yes Nothing Cold Intensity 
Threshold 
Goodin et al, 2012 PPC 12 12 Modified verbal, movement and eye fixation 
method + glove analgesia
Live Yes Nothing Cold Intensity 
Affect 
Tolerance
Facco et al, 2011 RM 31 31 Hypnosis with relaxation and well-being 
suggestions 
Live Yes Nothing Electric Threshold
Milling et al, 2010b RM 173 173  Hypnosis as per Spanos (1977) Live Yes Nothing Pressure Intensity
Milling et al, 2010a
(2 experiments)
PPC 52
143
52
143
Standard hypnotic induction + glove analgesic 
suggestion + relaxation
Live Yes Nothing Pressure Intensity
Green et al, 2010 BG 26 24 Stanford Hypnotic Clinical Scale + glove 
analgesic suggestion
Live Yes Nothing Ischemic Intensity
Williams et al, 2010 RM 33 33 Standard hypnotic induction Live Yes, No Not reported Electric Intensity
Milling et al, 2009 PPC 46 83 CURSS hypnotic induction with & without 45-sec 
glove analgesic suggestion 
Live Yes, No Placebo- sham oil 
labelled Trivaricaine 
Nothing  
Pressure Intensity 
Vanhaudenhuyse et 
al, 2009 
RM 13 13 Relaxation, fixation + memory recall Live No Nothing Laser Intensity
De Pascalis, 2008 RM 36 36 Stanford SHSS:C Live Yes, No Nothing Electric Intensity 
Affect 
Roder et al, 2007 RM 7 7 Hypnosis + Fixation + relaxation
Hypnosis +Fixation + depersonalization
Live No Nothing Electric Intensity
Casgalia et al, 2007 RM 20 20 Hypnosis with suggestion of relaxation and 
analgesia
Live Yes Nothing Cold Intensity 
Tolerance
Milling et al, 2007 PPC 42 41 CURSS Live Yes Placebo- sham oil 
labelled Trivaricaine 
Nothing
Pressure Intensity 
Sharav et al, 2006 RM 25 25 Hypnotic induction with generalized relaxation, 
guided imagery and focused analgesia
Live Yes Nothing Electric Intensity
Patterson et al, 2006 PPC 51 26 Stanford Hypnotic Clinical Scale with relaxation 
+ analgesic/no analgesic suggestion
Audio 
recording
Yes, No Nothing Heat Intensity 
Affect
Milling et al, 2005 RM 40 40 CURSS + glove analgesic suggestion Live Yes Placebo topical oil 
Nothing
Pressure Intensity 
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Rainville et al, 2005 RM 69 69 Standard hypnotic induction Live No Nothing Heat Intensity 
Affect
De Pascalis, Cacace et 
al, 2004 
RM 38 38 Stanford SHSS:C Live Yes, No Nothing Electric Intensity 
Affect
De Pascalis, Bellusci
 et al, 2004 
RM 30 30 Stanford SHSS:C with relaxation + dissociation Live Yes, No Placebo Cold Intensity
Sharav et al, 2004 RM 15 15 Hypnotic relaxation induction with/without 
focused analgesic suggestion
Live Yes, No Nothing Electric Intensity
Milling and Breen, 
2003 
PPC 55 55 CURSS with pain control or glove analgesic 
suggestion
Audio 
recording
Yes, No Placebo- sham oil 
labelled Trivaricaine 
Nothing
Pressure Intensity 
Milling, Levine et al, 
2003 
PPC 95 47 CURSS Live Yes, No Nothing Pressure Intensity 
Faymonville et al, 
2003 
RM 19 19 Hypnosis with eye fixation and muscle 
relaxation
Live Yes Nothing Heat Intensity 
Croft et al, 2002 BG 11 9 Hypnosis with relaxation, fixation and imagery Live Yes, No Oddball task Electric Intensity
Milling et al, 2002 PPC 22 18 CURSS + glove analgesia Live Yes Nothing Pressure Intensity 
Langlade et al, 2002 RM 15 15 Hypnosis with fixation, relaxation and analgesic 
suggestion
Live Yes Nothing Heat Threshold 
Tolerance 
Ray et al, 2002 RM 12 12 Stanford SHSS:C Audio 
recording
Yes Nothing Electric Intensity
Friederich et al, 2001 RM 20 20 Stanford Hypnotic Clinical Scale
glove analgesic suggestion + relaxation imagery 
Live Yes Nothing Heat Intensity 
Affect
Wright et al, 2001 PPC 30 28 Rapid induction Analgesia Live Yes Reading Chemical 
Pressure 
Intensity 
Affect 
Threshold 
Tolerance
De Pascalis et al, 2001 RM 29 29 Stanford SHSS:C with relaxation, dissociation 
and analgesic suggestion
Live Yes, No Nothing
Placebo topical 
anaesthetic
Electric Intensity 
Affect
Benhaiem et al, 2001 RM 32 32 Hypnosis with deep relaxation and focused 
analgesia
Live Yes, No Nothing Heat Threshold 
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Hofbauer et al, 2001 RM 10 10 Stanford SHSS:A Live Yes, No Nothing Heat Intensity 
Affect
Faymonville et al, 
2000 
RM 11 11 Stanford SHSS:C with muscle relaxation and
pleasant memory recall
Live No Nothing Heat Intensity 
Affect
Sandrini et al, 2000 RM 20 20 Standard hypnotic induction Live Yes Nothing Cold Tolerance
De Pascalis et al, 1999 RM 29 29 Stanford SHSS:C with relaxation, dissociative 
imagery and analgesic suggestion
Live Yes, No Nothing 
Placebo topical gel
Electric Intensity 
Affect
Threshold
Rainville et al, 1999 PPC 11 6 Stanford SHSS:A Live Yes Nothing Heat Intensity 
Affect
Milling et al, 1999 PPC 50 48 Stanford SHSS:C Audio 
recording
Yes Nothing Pressure Intensity
Danziger et al, 1998 RM 18 18 Hypnosis with deep relaxation, fixation and
Analgesic suggestion
Live Yes Nothing Electric Threshold
Zachariae et al, 1998 RM 20 20 Standard hypnotic induction Live Yes, No Nothing Electric Intensity
Rainville et al, 1997 RM 8 8 Stanford SHSS:A Live Yes, No Nothing Heat Intensity 
Affect
De Pascalis et al, 1997 RM 20 20 Stanford SHSS:C with subjective sensitivity to 
somatosensory stimuli emphasised 
Audio 
recording
Yes, No ‘normal attention’ 
control 
(recognition task) 
Electric Intensity
Threshold
De Pascalis et al, 1996 RM 16 16 Stanford SHSS:C Live Yes, No Nothing Electric Intensity 
Affect
Jacobs et al, 1995 RM 24 24 Stanford SHSS:C Audio 
recording
Yes Nothing Cold Intensity
Kiernan et al, 1995 RM 15 15 Hypnosis with suggestion of relaxation, comfort, 
and wellbeing
Live Yes Nothing Electric Intensity 
Affect
Hargadon et al, 1995 RM 66 66 Standard hypnotic induction with glove 
analgesic suggestion
Live Yes Nothing Pressure Intensity
Dahlgren et al, 1995 RM 16 16 Stanford hypnotic clinical scale with deep 
relaxation
Live Yes Nothing Cold Intensity 
Affect
Zachariae et al, 1994 RM 20 20 Hypnosis using eye fixation technique and 
standardised countdown deepening procedure 
with deep relaxation/ dissociative imagery/ 
focused analgesia
Live Yes, No Placebo 
anaesthetic spray
Laser Intensity
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Crawford et al, 1993 RM 11 11 Stanford SHSS:C with mention of sleep and 
drowsiness 
 
NG Yes, No Nothing Ischemic Intensity 
Affect
Maurer et al, 1993 RM 42 42 Direct hypnosis induction with focused attention 
and repetitive direct suggestion
Indirect hypnosis with ‘Rapid Induction 
Analgesia’ 
Live Yes Nothing Cold Intensity
Spanos et al, 1990
(2 experiments)
PPC
(RM)
15
28
15
28
Hypnosis (Barber, 1969) Audio 
recording
Yes Nothing Pressure Intensity
Tenenbaum et al, 
1990 
RM 48 48 Stanford Hypnotic Clinical Scale 
 
Audio 
recording
Yes Nothing Cold Tolerance
Malone et al, 1989 RM 45 45 Hypnosis (Barber, 1969) with relaxation and 
analgesic suggestion
Live Yes, No Nothing Electric Intensity 
Affect
Spanos, Perlini et al, 
1989 
2 experiments
PPC 64
60
32
30
Hypnosis (Barber, 1969) Live Yes Nothing Pressure Intensity 
Spanos and Katsanis, 
1989 
PPC 20 10 Hypnosis modified from Barber (1969) as 
passively (analgesia without voluntary effort) or 
actively (analgesia due to mental control) 
worded instructions
 
Live Yes Nothing Pressure Intensity
De Benedettis et al, 
1989 
RM 21 21 Standard hypnotic induction Live Yes` Nothing Ischemic Affect
Tolerance 
Spanos et al, 1988 PPC 45 15 Hypnosis (Barber, 1969) Live Yes Nothing Pressure Tolerance
Price et al, 1987 RM 16 16 Standard hypnotic induction Live Yes Nothing Heat Intensity
Affect
Stam et al, 1987 RM 32 32 Standard hypnotic Induction Live Yes Nothing Ischemic Threshold 
Tolerance
Spanos et al, 1986 PPC 64 32 Hypnosis (Barber, 1969) Audio 
recording
Yes Nothing Pressure Intensity
Tolerance
Van Gorp et al, 1985 PPC 20 20 Rapid induction analgesia which includes 
suggestion of relaxation and altering memory 
Standard hypnotic induction 
Audio 
recording
Yes, No Nothing Cold Intensity
Spanos et al, 1985 PPC 21 19 Hypnosis (Barber, 1969) Audio 
recording
Yes Nothing Cold Tolerance
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Fricton et al, 1985 RM 10 10 Indirect hypnosis induction uses language that is 
individualised – implies control rests with the 
subject 
Direct hypnosis induction uses focused attention 
and repetitive direct suggestion
Live No Nothing Electric Threshold
Spanos et al, 1984 RM 75 75 Hypnosis (Barber, 1969) Live Yes Nothing Cold Intensity
Stam et al, 1984 
(2 experiments)
RM
(PPC)
16
10
16
10
Standard hypnotic induction Audio 
recording
Yes Nothing Ischemic Threshold 
Tolerance
Spanos et al, 1983 RM 16 16 Hypnosis (Barber, 1969) with suggestions of 
more or less aware of pain from overt and 
hidden part of body
Audio 
recording
Yes Nothing Cold Intensity
Karlin et al, 1980 RM 11 11 Standard hypnotic induction
 
Audio 
recording
Yes Nothing Cold Intensity
Spanos et al, 1980 RM 8 8 Hypnotic induction with hidden observer cues
 
Audio 
recording
Yes Nothing Cold Intensity
Stam et al, 1980 PPC 20 10 Standard hypnotic procedure Live Yes Nothing Cold Intensity
Wood et al, 1976 PPC 10 10 Standard hypnotic induction Audio 
recording
No Nothing Cold Tolerance
Lli et al, 1975 RM 14 14 Standard hypnotic induction with relaxation Live Yes Nothing Electric Tolerance
Threshold
Greene et al, 1972 RM 36 36 Standard hypnotic induction with pleasant 
imager with/without analgesic suggestion 
Live Yes, No Nothing Electric Tolerance
Morgan et al, 1970 RM 12 12 Standard hypnotic induction NG Yes Nothing Cold Intensity
Evans et al, 1970 PPC 32 16 Hypnotic induction with eye fixation & 
relaxation
Live Yes, No Nothing Cold Affect
Key. RM=repeated-measures; BG=between-groups; PPC=pre-post control; CURSS=Carlton University Responsiveness to Suggestion Scale; SHSS=Stanford Hypnotic Suggestibility 
Scale (Forms A and C).
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Table 2. Meta-regression estimates of unstandardized (0-10) pain intensity ratings and 95% 
confidence intervals (CI).
Estimate 95% CI p
Intercept 0.03 -0.59, 0.64 .931
Hypnotisability (Medium) 0.64 0.26, 1.03 .003
Hypnotisability (High) 1.34 0.75, 1.93 <.001
Analgesic suggestion (Yes) 0.94 0.25, 1.63 .009
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Figure 2. Forest plot of pain intensity
SMD
 (Pain Intensity Ratings)
St
an
da
rd
 E
rro
r
0.
83
1
0.
62
3
0.
41
6
0.
20
8
0
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
−1 0 1 2
Appendix S1. Search terms for PubMed
(hypno* OR trance) AND (pain OR nocicept* OR  analge*) AND (threshold OR 
tolerance OR cold OR heat OR thermal OR ischemi* OR ischaemi* OR chemical OR 
pressure OR mechanical OR electric* OR chemical OR capsaicin OR reflex OR 
experimental OR acute)
 
Appendix S2. Endorsement of validity criteria (1= criteria met, 0= criteria not met)
Study q1 q2 q3 q4 q5 q6 q7 q8 q9 q10 q11 q12 q13 q14 q15
Derbyshire et al (2017) 1 1 1 0 0 0 1 1 1 0 1 1 1 1 1
Bhatt et al (2017) 1 1 0 1 1 0 1 1 1 1 0 1 1 1 0
Fidanza et al (2017) 1 1 0 1 0 1 1 1 0 0 1 1 1 1 0
Casiglia et al (2017) 1 0 0 0 0 0 1 1 0 0 0 1 0 1 0
Braboszcz et al (2017) 1 1 1 0 0 0 0 1 1 1 1 1 1 1 1
Wolf et al (2016) 1 1 1 1 0 1 0 1 1 0 0 1 0 1 1
DePascalis et al (2016) 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0
DePascalis et al (2015) 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1
Kramer et al (2014) 1 0 1 1 0 0 1 1 1 0 1 1 1 1 0
Swain et al (2014) 1 1 1 1 1 0 1 1 0 1 0 0 1 1 0
Enea et al (2014) 1 1 1 0 0 0 1 1 1 1 1 1 0 1 1
Valentini et al (2013) 1 0 0 1 1 1 1 1 1 0 1 1 1 1 1
Santarcangelo et al (2013) 1 1 1 1 1 0 1 1 0 1 1 1 1 1 0
Goodin et al (2012) 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1
Facco et al (2011) 1 1 0 1 1 1 1 1 1 0 1 1 1 1 0
Williams et al (2012) 1 0 0 0 0 0 1 1 0 0 1 1 1 1 1
Milling et al (2010) 1 1 1 0 0 0 1 0 0 1 1 1 1 1 0
Green et al (2010) 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0
Milling et al  (2010) 1 1 1 1 1 0 1 1 0 1 0 0 1 1 0
Milling et al  (2009) 1 1 1 0 1 0 1 1 1 1 1 0 1 1 1
Vanhaudenhuyse et al (2009) 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1
DePascalis et al (2008) 1 1 0 1 1 1 1 1 0 1 1 1 1 1 1
Roder et al (2007) 1 0 0 0 0 0 1 1 1 0 1 0 1 1 0
Casiglia et al (2007) 1 0 0 0 0 1 1 1 1 0 0 1 1 1 0
Milling et al (2007) 1 1 1 0 0 0 1 1 1 1 1 0 1 1 1
Sharav et al (2006) 1 1 1 0 0 0 1 1 1 0 1 1 1 1 0
Patterson et al (2006) 1 1 0 0 0 0 1 1 1 0 1 0 1 1 1
Milling et al (2005) 1 1 1 0 0 0 1 1 1 1 1 0 0 1 1
Rainville et al (2005) 1 1 0 0 0 0 1 1 0 1 1 1 1 1 0
DePascalis, Cacace et al (2004) 1 1 0 0 0 0 1 1 0 1 1 1 1 1 1
DePascalis, Bellusci et al (2004) 1 1 1 1 0 0 1 1 1 0 1 1 1 1 0
Sharav et al (2004) 1 1 1 1 0 1 1 1 1 1 1 1 1 1 0
Milling, Breen et al (2003) 1 1 1 0 0 0 1 1 1 1 1 0 0 1 1
Faymonville et al (2003) 1 0 0 0 0 0 1 1 1 1 1 1 1 1 0
Milling, Levine et al (2003) 1 1 1 0 0 0 1 1 1 0 1 0 0 1 1
Croft et al (2002) 1 1 1 0 0 0 1 1 1 0 1 0 1 1 1
Milling et al (2002) 1 1 1 0 0 0 1 1 1 1 1 1 0 1 1
Langlade et al (2002) 0 1 1 0 0 0 1 1 0 0 0 1 1 1 1
Ray et al (2002) 1 1 0 0 0 0 0 1 0 1 0 1 1 1 0
Wright et al (2001) 1 1 1 0 0 0 1 1 1 0 0 1 1 1 0
DePascalis et al (2001) 1 1 0 1 0 0 1 1 1 1 1 1 1 1 0
Benhiem et al (2001) 1 0 1 1 0 1 1 1 1 0 1 1 1 1 0
Hofbauer et al (2001) 1 0 0 0 0 0 1 1 1 1 1 1 1 1 0
Freiderich et al (2001) 1 1 1 0 0 0 1 1 1 1 1 0 0 1 1
Faymonville et al (2000) 1 0 0 0 0 1 1 1 0 0 1 1 1 1 0
Sandrini et al (2000) 1 1 0 0 0 1 1 1 1 0 1 1 1 1 1
DePascalis et al (1999) 1 0 0 0 0 0 1 1 1 1 1 1 1 1 0
Rainville et al (1999) 1 1 0 0 0 0 1 1 1 1 0 1 1 1 0
Milling et al (1999) 1 1 1 0 0 0 1 1 0 0 1 1 0 1 1
Danzinger et al (1998) 1 1 0 1 0 1 0 1 1 0 1 1 0 1 0
Zachariae et al (1998) 1 0 1 0 0 0 1 1 1 1 1 0 1 1 0
Rainville et al (1997) 1 0 0 0 0 0 0 1 0 1 1 1 0 1 0
DePascalis et al (1997) 1 1 1 0 0 0 1 1 0 0 1 1 0 1 0
DePascalis et al (1996) 1 1 0 0 0 0 1 1 0 1 1 1 1 1 0
Jacobs et al (1995) 1 1 1 0 0 0 1 1 0 0 1 1 0 1 0
Kiernan et al (1995) 1 1 1 1 0 1 1 0 1 0 0 1 1 1 0
Hargadon et al (1995) 1 0 0 0 0 0 1 1 1 1 1 1 0 1 0
Dahlgren et al (1995) 1 1 0 1 0 1 0 0 0 1 1 1 0 1 0
Zachariae et al (1994) 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1
Maurer et al (1993) 1 1 0 0 0 0 1 1 1 1 1 1 1 1 0
Crawford et al (1993) 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1
Spanos et al  (1990) 1 1 1 0 0 0 1 1 1 1 1 0 0 1 1
Tenenbaum et al (1990) 1 0 1 1 0 1 1 1 0 0 1 0 0 1 0
Malone et al (1989) 0 1 1 0 0 0 1 1 1 0 1 0 0 1 1
Spanos, Perlini et al (1989) 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1
Spanos and Katsanis et al (1989) 1 1 1 0 0 0 1 1 1 1 1 0 0 1 1
Debenedittis et al (1989) 1 1 1 0 0 0 1 1 1 0 1 1 1 1 0
Spanos et al (1988) 1 1 1 0 0 0 1 1 1 1 1 0 1 1 1
Stam et al (1987) 1 1 1 1 0 1 1 1 0 1 0 1 1 1 0
Price et al (1987) 1 1 1 0 0 0 1 1 1 0 0 1 1 1 0
Spanos et al (1986) 1 1 1 0 0 0 1 1 1 1 1 1 0 1 1
VanGorp et al (1985) 1 1 0 0 0 0 1 1 1 1 1 1 0 1 1
Spanos et al (1985) 1 1 1 0 0 0 1 1 1 1 0 1 0 1 1
Fricton et al (1985) 1 0 0 0 0 0 1 1 1 0 1 1 0 1 0
Spanos et al (1984) 1 1 1 0 0 0 1 1 1 0 1 1 1 1 1
Stam et al  (1984) 1 1 1 1 1 0 1 1 1 1 1 0 1 1 0
Spanos et al (1983) 1 1 1 1 0 0 1 1 1 0 1 1 0 1 0
Karlin et al (1980) 0 1 1 1 0 0 1 1 0 0 1 1 1 1 0
Stam et al (1980) 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1
Spanos et al (1980) 1 1 1 0 0 0 1 1 1 1 1 1 0 1 0
Wood et al (1976) 1 1 0 0 0 0 1 1 1 1 1 0 0 1 0
Li et al (1975) 0 1 0 1 1 0 0 1 1 1 0 0 1 1 0
Greene et al (1972) 1 1 1 0 0 0 1 1 1 1 1 1 0 1 1
Morgan et al (1970) 1 0 0 0 0 0 1 1 0 0 1 1 0 1 0
Evans et al (1970) 1 1 1 0 0 0 1 1 1 0 1 0 1 1 0
Mean Item Endorsement 0.95 0.79 0.64 0.34 0.18 0.25 0.92 0.96 0.71 0.59 0.82 0.73 0.67 1.00 0.42
Key: 1-Was there a clear specification of study objectives; 2-Was it clearly described where particpants were drawn from (e.g. University etc); 3-Was it clearly described how participants were 
recruited (e.g. advertisement, course credits, volunteers etc etc); 4-Was there a clear description of the inclusion and exclusion criteria; 5-Were participants assessed to see if they had pre-
existing pain; 6-Were participants asked to report (or abstain from using) any medication that might affect their experience of pain (e.g. painkilllers); 7-Pain Assessment: Was the method of 
pain assessment clearly described; 8-Pain Induction: Was the  method of pain induction clearly reported; 9-Hypnosis: Was the hypnotic intervention described in adequate detail; 10-Control: 
Was the control condition described in adequate detail; 11-Was hypnotisability assessed; 12-Comparability of cases and controls; 13-Were relevant participant characteristics adequately 
described (age, sex etc); 14-Were complete outcome data (i.e., Ms and SDs) available  (e.g. reported in article or given via response to data request); 15-Were paticipants randomly allocated 
to groups (independent-sample designs) or presentation order (repeated-measures designs)?
PRISMA 2009 Checklist
`Section/topic # Checklist item Reported on page #
TITLE 
Title 1 Identify the report as a systematic review, meta-analysis, or both. 1
ABSTRACT 
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number. 
2
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is already known. 3
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS). 
4
METHODS 
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number. 
5
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale. 
5
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched. 
5
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated. 
Appendix 
S1
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis). 
6
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators. 
7
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made. 
7
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis. 
Table S1
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). 8
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I2) for each meta-analysis. 
9
PRISMA 2009 Checklist
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Section/topic # Checklist item Reported on page #
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies). 
10
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified. 
9
RESULTS 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram. 
10, 
Fgiure 1
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations. 
11, Table 
1
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). 12, Table 
S1
Results of individual studies 20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot. 
Figure 2
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. 13-14
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). 14
Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]). 14-15
DISCUSSION 
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers). 
16
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias). 
19
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future research. 17, 19
FUNDING 
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review. 
20
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097 
For more information, visit: www.prisma-statement.org. 
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